Donnatal Side Effects
Generic name: atropine / hyoscyamine / phenobarbital / scopolamine
Medically reviewed by Drugs.com. Last updated on Aug 22, 2024.
Note: This document provides detailed information about Donnatal Side Effects associated with atropine / hyoscyamine / phenobarbital / scopolamine. Some dosage forms listed on this page may not apply specifically to the brand name Donnatal.
Applies to atropine / hyoscyamine / phenobarbital / scopolamine: oral elixir, oral tablet.
Common side effects of Donnatal
Some side effects of atropine / hyoscyamine / phenobarbital / scopolamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- constipation
- decreased sweating
- dizziness
- dry mouth, nose, throat, or skin
Less common or rare side effects
Serious side effects of Donnatal
Along with its needed effects, atropine/hyoscyamine/phenobarbital/scopolamine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking atropine / hyoscyamine / phenobarbital / scopolamine:
Rare side effects
- eye pain
- skin rash or hives
- sore throat and fever
- unusual bleeding or bruising
- yellow eyes or skin
For healthcare professionals
Applies to atropine / hyoscyamine / phenobarbital / scopolamine: oral capsule, oral liquid, oral solution, oral tablet, oral tablet extended release.
Genitourinary adverse events
Cardiovascular
- Frequency not reported: Tachycardia, palpitation[Ref]
Ocular
- Frequency not reported: Blurred vision, mydriasis, cycloplegia, increased ocular tension[Ref]
Gastrointestinal
- Frequency not reported: Xerostomia, constipation, bloated feeling[Ref]
Nervous system
- Frequency not reported: Loss of taste sense, headache, drowsiness, dizziness, convulsions[Ref]
Hypersensitivity
- Frequency not reported: Severe allergic reaction or drug idiosyncrasies (including anaphylaxis, urticaria, and other dermal manifestations), acquired hypersensitivity (reactions include localized swelling, particularly of eyelids, cheeks, or lips, and erythematous dermatitis)[Ref]
Musculoskeletal
- Frequency not reported: Musculoskeletal pain[Ref]
Psychiatric
- Frequency not reported: Nervousness, insomnia, excitement, delirium, agitation (elderly patients)[Ref]
Dermatologic
- Frequency not reported: Decreased sweating, exfoliative dermatitis (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis)[Ref]
Hematologic
Other
- Frequency not reported: Weakness[Ref]
References
1. (2022) "Product Information. Donnatal (atropine/hyoscyamine/PB/scopolamine)." Concordia Pharmaceuticals
2. "Product Information. Belladonna-Phenobarbital (atropine/hyoscyamine/PB/scopolamine)." West-Ward Pharmaceuticals Corporation (previously Roxane Laboratories Inc)
More about Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (53)
- Drug images
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
- En español
Patient resources
- Donnatal drug information
- Donnatal (Advanced Reading)
- Donnatal (Hyoscyamine, Atropine, Scopolamine, and Phenobarbital Elixir)
- Donnatal (Hyoscyamine, Atropine, Scopolamine, and Phenobarbital Tablets)
Other brands
Antispasmodic, Phenohytro, Hyosophen, D-Tal, Se-Donna PB HYOS
Professional resources
Other brands
Related treatment guides
Further information
Donnatal side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.